Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Home > Adult Care: Treatment and Support > Treatment Centers and Clinical Services > Thoracic Cancer Treatment Center > Understanding lung cancer risk in patients with inherited EGFR T790M mutations > Eligibility Survey
The purpose of this study is to understand whether inherited EGFR T790M mutations lead to an increased risk of developing lung cancer. This study will lay the groundwork for identifying strategies to reduce the risk of developing lung cancer when an inherited mutation is present. Because individuals and families carrying inherited T790M mutations may not be able to travel to Dana-Farber, we have set up this online survey so that patients not treated at Dana-Farber Cancer Institute may participate remotely in our research study.
Find out more about this research study
This research study is currently open for the following groups of patients and individuals who may be at risk of carrying an inherited T790M mutation:
If you think you may be at risk of carrying an inherited T790M mutation and would like to participate in this study, please complete the form below.
All fields are required.